Lung Cancer, Non-squamous, Non-small Cell Clinical Trials in Madrid
2 recruitingMadrid, Spain
Showing 1–2 of 2 trials
Recruiting
Phase 2
Beamion 44: A Study to Test How Well Zongertinib is Tolerated by People With Advanced Non-small Cell Lung Cancer With HER2 Mutations When Given in Combination With Chemotherapy With or Without Pembrolizumab
Lung Cancer, Non-squamous, Non-small Cell
Boehringer Ingelheim60 enrolled17 locationsNCT07486817
Recruiting
Phase 3
Beamion LUNG-2: A Study to Test Whether Zongertinib (BI 1810631) Helps People With Advanced Non-small Cell Lung Cancer With HER2 Mutations Compared With Standard Treatment
Lung Cancer, Non-squamous, Non-small Cell
Boehringer Ingelheim416 enrolled162 locationsNCT06151574